Skip to main content
Top
Metadata
Title
Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis
Authors
Hendrik Seeliger
Markus Guba
Axel Kleespies
Karl-Walter Jauch
Christiane J. Bruns
Publication date
01-12-2007
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 3-4/2007
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-007-9077-8

Other articles of this Issue 3-4/2007

Cancer and Metastasis Reviews 3-4/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine